Skip to main content
BIO PROTECH INC. logo

BIO PROTECH INC. — Investor Relations & Filings

Ticker · 199290 ISIN · KR7199290008 LEI · 988400TYKP3J6SZOGR02 KO Manufacturing
Open in API
Filings indexed 281 across all filing types
Latest filing 2022-08-01 Delisting Announcement
Country KR South Korea
Listing KO 199290

About BIO PROTECH INC.

https://www.protechsite.com/

BIO PROTECH INC. is a manufacturer of medical equipment and disposable supplies. The company develops and produces a range of products for applications in surgery, cardiology, neurology, and pain management. Its portfolio includes electrosurgical devices such as smoke evacuators and surgical pencils, various electrocardiogram (ECG) electrodes, and transcutaneous electrical nerve stimulation (TENS) units. The company specializes in bio-medical sensors and related products developed using advanced skin technology for the global healthcare market.

Recent filings

Filing Released Lang Actions
주권매매거래정지(지정자문인 선임계약 해지)
Delisting Announcement Classification · 1% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for a specific company due to the termination of a designated advisor contract. This is a regulatory announcement regarding market status and does not fit into specific categories like earnings or dividends. As it is a regulatory notice regarding trading status, it falls under the RNS category.
2022-08-01 Korean
기타시장안내(지정자문인 선임계약 해지에 따른 상장폐지절차 안내)
Delisting Announcement Classification · 1% confidence The document is a short announcement regarding the delisting process of BioProtech due to the termination of a designated advisor contract. It explicitly mentions '상장폐지절차 안내' (Delisting procedure notice) and outlines the consequences of failing to appoint a new advisor. This fits the definition of a Delisting Announcement (DLST).
2022-08-01 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding a 'Capital Increase Decision' (유상증자결정). It specifically details a correction (정정신고) to a previous filing, noting that the capital increase was cancelled due to non-payment by the designated third party. This falls under the category of capital structure changes and financing updates.
2022-07-29 Korean
증권발행결과(자율공시)(제3자배정_전환상환우선주_납입일 22.7.29_납입금 미납 불발행)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement from BioProtec, detailing the outcome of a third-party allocation of convertible redeemable preferred shares. It explicitly states that the issuance did not occur due to non-payment by the designated parties. This falls under the category of share issuance or capital change announcements.
2022-07-29 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing regarding the exercise of conversion rights (전환청구권 행사) for convertible bonds. It details the conversion of debt into equity, which results in the issuance of new shares. This falls under the category of capital changes or share issues resulting from corporate financing activities. Given the specific nature of convertible bond exercises, it is classified as a share issue/capital change announcement.
2022-07-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (directors/executives) due to a third-party capital increase. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-06-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.